International Alzheimer’s Clinical Trial to Test Tau Drugs A worldwide clinical trial aimed at finding treatments for Alzheimer’s disease has expanded to include investigational drugs targeting a harmful form of the brain protein tau. The trial, known as the Dominantly Inherited Alzheimer Network Trials Unit (DIAN-TU) and led by Washington
MU Among First Institutions to Enroll Patient in International COVID-19 Clinical Trial The University of Missouri School of Medicine is one of the first institutions in the world to enroll a patient in a new National Institutes of Health (NIH) clinical trial designed to test the safety, tolerability and efficacy
Experimental Drug Shows Early Promise Against Inherited Form of ALS, Trial Indicates An experimental drug for a rare, inherited form of amyotrophic lateral sclerosis (ALS) has shown promise in a phase 1/phase 2 clinical trial conducted at Washington University School of Medicine in St. Louis, Massachusetts General Hospital in Boston
Saint Luke’s Cardiologist Leads Trial to See if Diabetes Drug Can Prevent Serious Covid-19 Complications
Saint Luke's Cardiologist Leads Trial to See if Diabetes Drug Can Prevent Serious Covid-19 Complications Saint Luke's Mid America Heart Institute and drug company AstraZeneca PLC are conducting a clinical trial to see if a drug now used to treat diabetes could help prevent deadly complications in COVID-19 patients. Read
Study to Evaluate Antidepressant as Potential COVID-19 Treatment Researchers at Washington University School of Medicine in St. Louis are launching a clinical trial in patients who have tested positive for COVID-19 but who are not sick enough to be hospitalized. Read more...
From Scorpion to Immunotherapy: City of Hope Scientists Repurpose Nature’s Toxin for First-Of-Its Kind Car T Cell Therapy to Treat Brain Tumors
From Scorpion to Immunotherapy: City of Hope Scientists Repurpose Nature’s Toxin for First-Of-Its Kind Car T Cell Therapy to Treat Brain Tumors City of Hope scientists have developed and tested the first chimeric antigen receptor (CAR) T cell therapy using chlorotoxin (CLTX), a component of scorpion venom, to direct T
Trials by Fire Since its inception in 2005, the University of Missouri Thompson Center for Autism and Neurodevelopmental Disorders has served as a national leader in autism research, advancing the field by improving diagnostic measures, identifying genetic markers that cause autism, and developing effective behavioral treatments for people on the
For The First Time Ever, A Drug Developed By AI Will Be Tested In Human Trials In a world first, a medicine developed by artificial intelligence may be used to treat patients with obsessive-compulsive disorder. The news is remarkable and hints that in the future, AI may help drug development
KU Cancer Center - Invented Drug Targets Transforming Bladder Treatment CicloMed LLC has expanded a clinical trial for an anti-cancer drug that could potentially transform the treatment of bladder cancer. Read more...
Restoring Arm, Hand Function After Spinal Cord Injury Focus of Clinical Trial Spinal cord injuries caused by accidents, violence and disease paralyze from the neck down more than 5,000 people every year. In the first few months after injury, some people regain some movement and sensation in their limbs. Those